Document Classification

Section Type: RESULTS

Text: The treatment in the test group showed an effect better than that in the control group in terms of reducing blood pressure variability and night-time blood pressure decrease rate (P < 0. 05), with the total effective rate and markedly effective rate in lowering blood pressure superior to the control group (P < 0. 05), alleviating symptoms as headache, soreness and weakness of the waist and knees, and insomnia (P < 0. 05), and decreasing levels of heart rate, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), Hs-CRP and Ang II (P < 0. 05), The plasma level of endogenous E2 was elevated after treatment in the test group (P < 0. 05), but showed no statistical difference in the control group.